Cytophenix
Cytophenix is revolutionizing the fight against life-threatening infections with their rapid antimicrobial susceptibility tests. Their breakthrough technology delivers swift, precise results, enabling doctors to quickly identify the most effective antibiotics for each patient. This not only enhances treatment but also curtails the use of ineffective antibiotics, tackling antimicrobial resistance head-on.
Developed by a multidisciplinary team of expert researchers, clinicians, and engineers, Cytophenix is working to significantly reduce the time to personalised treatment recommendations, improve patient outcomes and save lives. Cytophenix is redefining infection management, helping patients get the right treatment at the right time, every time.
To find out more, visit our website at https://cytophenix.com/, or contact us at kieran@cytophenix.com.
Meet the team
Cytophenix: Kieran Mulroney, Christine Carson, Sherief Khorshid, Teagan Paton, James Telders, Tim Inglis
Watch our presentation at the ON Accelerate 8 Showcase
Held in Melbourne on 5 June 2024. Our team was one of nine that shared their learnings to a crowd of investors, industry experts, ON Alumni and ecosystem supporters. Below is a recording of our presentation.